This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Systemic Lupus Erythematosus
  • /
  • Study of Recombinant Human B Lymphocyte(RC18) Admi...
Clinical trial

Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)

Read time: 1 mins
Last updated:2nd Dec 2019
Status: Recruiting
Identifier: NCT04082416
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest